N Bormann1, A Pruss, G Schmidmaier, Britt Wildemann. 1. Julius WolV Institut, Center for Musculoskeletal Surgery, Berlin-Brandenburg Center for Regenerative Therapies, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Abstract
INTRODUCTION: Bony allografts are used frequently in the clinic for bone defect filling, however, less comparative data concerning their osteoinductive potential are available. AIM: The purpose of the present study was the comparative analysis of different allograft preparations. From five donors, we investigated fresh-frozen cancellous bone (native), peracetic acid–ethanol sterilized (PES) cancellous bone, cortical bone and demineralised bone matrix (DBM). In addition, two commercially available DBM products from five different donors were analyzed: Allomatrix® (Wright Medical Technology Inc.) and DBX putty® (Synthes GmbH). For positive control and as a clinically used growth factor, BMP-2 was chosen. METHOD: To investigate the osteoinductivity C2C12 cells were cultured with the different materials and the effect on cell proliferation and alkaline phosphatase activity were measured. RESULT: Proliferation was significantly enhanced by the native cancellous bone, Allomatrix, and BMP-2 and decreased by the PES-processed cancellous bone. The osteogenic differentiation was significantly enhanced by BMP-2 and the two commercial DBM products and decreased by PES-sterilized cancellous bone. All tested materials revealed a high donor-dependent variability. This is the first comparative study on the osteoinductivity of bony allografts frequently used in clinic.
INTRODUCTION: Bony allografts are used frequently in the clinic for bone defect filling, however, less comparative data concerning their osteoinductive potential are available. AIM: The purpose of the present study was the comparative analysis of different allograft preparations. From five donors, we investigated fresh-frozen cancellous bone (native), peracetic acid–ethanol sterilized (PES) cancellous bone, cortical bone and demineralised bone matrix (DBM). In addition, two commercially available DBM products from five different donors were analyzed: Allomatrix® (Wright Medical Technology Inc.) and DBX putty® (Synthes GmbH). For positive control and as a clinically used growth factor, BMP-2 was chosen. METHOD: To investigate the osteoinductivity C2C12 cells were cultured with the different materials and the effect on cell proliferation and alkaline phosphatase activity were measured. RESULT: Proliferation was significantly enhanced by the native cancellous bone, Allomatrix, and BMP-2 and decreased by the PES-processed cancellous bone. The osteogenic differentiation was significantly enhanced by BMP-2 and the two commercial DBM products and decreased by PES-sterilized cancellous bone. All tested materials revealed a high donor-dependent variability. This is the first comparative study on the osteoinductivity of bony allografts frequently used in clinic.
Authors: Huipin Yuan; Hugo Fernandes; Pamela Habibovic; Jan de Boer; Ana M C Barradas; Ad de Ruiter; William R Walsh; Clemens A van Blitterswijk; Joost D de Bruijn Journal: Proc Natl Acad Sci U S A Date: 2010-07-19 Impact factor: 11.205
Authors: Christian Fölsch; Wolfram Mittelmeier; Uwe Bilderbeek; Nina Timmesfeld; Thomas von Garrel; Hans Peter Matter Journal: Transfus Med Hemother Date: 2011-12-27 Impact factor: 3.747
Authors: Joana M Ramis; Javier Calvo; Aina Matas; Cristina Corbillo; Antoni Gayà; Marta Monjo Journal: J Mater Sci Mater Med Date: 2018-06-28 Impact factor: 3.896
Authors: Daniel N Bracey; Alexander H Jinnah; Jeffrey S Willey; Thorsten M Seyler; Ian D Hutchinson; Patrick W Whitlock; Thomas L Smith; Kerry A Danelson; Cynthia L Emory; Bethany A Kerr Journal: Cells Tissues Organs Date: 2019-10-25 Impact factor: 2.481